To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2

NCT05200741 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: DelNS1-2019-nCoV-RBD-OPT1
BIOLOGICAL: Matching placebo

Sponsor

The University of Hong Kong